Navigation Links
Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer

Clone Systems' headquarters and research operations are located in New York City, with additional administration and manufacturing facilities in Branchburg, New Jersey.

Certain matters discussed in this news release may constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the company's ability to control or predict. Important factors that may cause actual results to differ materially and could impact the company and the statements contained in this news release can be found in the company's filings with the Securities and Exchange Commission, including quarterly reports on Form 10-Q, current reports on Form 8-K and annual reports on Form 10-K. For forward-looking statements in this news release, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.

Bristol-Myers Squibb is dedicated to the discovery, development and exhaustive exploration of innovative cancer fighting therapies designed to extend and enhance the lives of patients living with cancer. More than 40 years ago, Bristol-Myers Squibb built a unified vision for the future of cancer treatment. With expertise, dedication and resolve, that vision led to the development of a diverse global portfolio of anti-cancer therapies that are an important cornerstone of care today. Hu
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
3. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
4. Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
5. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6. Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:4/23/2015)... OTTAWA , April 23, 2015 /CNW/ - Health ... oral ibuprofen products to update the safety information regarding ... attack and stroke) when these products are used at ... increases with dose and duration of use. ... pain and fever relief, and to reduce inflammation. The ...
(Date:4/23/2015)... Apr. 23, 2015 Surna, Inc. (OTCQB: SRNA), ... state-of-the art equipment and systems for controlled environment ... cannabis cultivation, will host a shareholder conference call ... 2015, at 4:15 PM Eastern Standard Time/1:15 PM ... call will be listen-in only, but will include ...
(Date:4/23/2015)... 23, 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ... at the Deutsche Bank 40 th Annual Health ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://edge.media-server.com/m/p/yvym8uoy ... available one hour after conclusion of the live event ...
Breaking Medicine Technology:Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3
... PRINCETON, N.J., Feb. 1, 2011 Soligenix, Inc. (OTC ... Company), a late-stage biopharmaceutical company, announced today that it ... President and Chief Medical Officer. Dr. Horgan is a ... and experience in the care of patients with inflammatory ...
... AssureRx Health, Inc. today announced the appointments of two ... Donald R. Wright, Jr. has been appointed as executive ... Bellano as senior vice president, sales & commercial programs. ... of AssureRx,s pharmacogenetic test, GeneSightRx®, and the blueprint ...
Cached Medicine Technology:Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer 2Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer 3Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer 4AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth 2AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth 3
(Date:4/24/2015)... Vancouver, BC (PRWEB) April 24, 2015 ... Albert Yuzpe, Olive Fertility co-founder and co-director, has been ... Fertility Preservation at the Evening of Hope Gala. ... to recognize Dr. Albert Yuzpe, who has been at ... past 43 years,” says Jessica Séguin, Executive Director of ...
(Date:4/24/2015)... April 24, 2015 National Access ... and legal access to medical cannabis, is taking a ... supported when advising patients. , NAC is the first ... With a $250,000 grant, NAC will be providing 300 ... "Our goal is to help Canadians gain safe and ...
(Date:4/24/2015)... April 24, 2015 Telematics Berlin is ... automakers, tier 1 & 2 suppliers, content providers, associations ... players in the value chain, see them converge in ... not only hear from those companies currently at the ... future partners. Working on customer centric products, ParkTAG are ...
(Date:4/24/2015)... PURE Solutions, a leader in allergy travel ... Network), a highly respected education, advocacy and community out-reach ... information for a special allergy travel section ... goal for both organizations is to “make lives better” ... with asthma and allergies and by finding effective ways ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 ProTube Outro is ... Pro X video editors. ProTube Outro allows editors to ... 5 video drop zones. Position, scale, and rotate pictures/videos, ... ProTube Outro uses simple borders and shadows for a ... exclusive plugin. , ProTube Outro comes packed with over 30 ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:PURE Solutions Partners with Allergy and Asthma Network to Provide Allergy Travel Tips 2Health News:Pixel Film Studios, FCPX Plugin Developer Announced the Release of Protube Outro, Outro Screen Templates for Final Cut Pro X 2
... sexually transmitted infections to tell their partners// to seek ... or drugs to help reduce infection rates, says a ... an important part of managing most curable sexually transmitted ... often makes this difficult. ,Researchers analysed ...
... is in the process of doing away with a commonly ... phase out the ‘Aropax’ brand of paroxetine and bring in ... used by about 49,000 New Zealanders. ,This move ... maintains that both drugs are the same, except for the ...
... supplements of folic acid could improve the memory and ... researchers from the University of Wageningen gave a group ... acid supplements or a dummy drug for three years, ... ,The folic acid group had significantly better memories and ...
... are helping to lead a large international study // ... in an effort to determine whether exercise really is ... promoted the value of exercise for a variety of ... established as safe in the group of patients who ...
... light of new information on facial transplantation—including the psychological ... of the Royal College of Surgeons of England now ... according to a report published in the Jan. 27 ... in 2003, the Working Party concluded that facial transplantation ...
... It’s no secret why we shed tears. But exactly what our ... ,A new study sheds some light on the complex design ... film, which is made up of three distinct, microscopic layers. The ... when we cry – is sandwiched between a layer of mucus ...
Cached Medicine News:Health News:New International Study to Test Exercise in Heart Failure Patients 2Health News:New International Study to Test Exercise in Heart Failure Patients 3Health News:Royal College Issues Revised Guidelines for Face Transplantation 2Health News:Royal College Issues Revised Guidelines for Face Transplantation 3Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 2Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 3
For the quantitative determination of total cholesterol in human serum....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
For the quantitative in vitro determination of lithium in serum and plasma. Wavelength: 550 nm. Linear range: up to 4 mm....
This True 12-bit integrated and cooled system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lighting....
Medicine Products: